Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Enyo Pharma S.A.

Headquarters: Lyon, France
Year Founded: 2014
Status: Private

BioCentury | Jan 4, 2024
Finance

Jan. 3 Quick Takes: Goldman Sachs unveils $650M life sciences fund

Plus: Arrowhead trades up as $450M follow-on extends runway and updates from Remix, CG Oncology, Agios, Boehringer-Ribo, Enyo
BioCentury | Nov 1, 2018
Finance

OrbiMed’s NASH Terns

Why OrbiMed led $80 million B round for U.S.-China NASH company Terns
BioCentury | Jun 8, 2018
Financial News

Metacrine raises $65M series C

BioCentury | Jun 6, 2018
Financial News

Metacrine raises $65M series C

Items per page:
1 - 10 of 13